DOCU vs EXEL · P/E 15, rev $1.71B vs P/E 17, rev $1.24B
DocuSign Inc (DOCU) versus Exelixis Inc (EXEL) — a side-by-side from cached financials, not a winner call.
DocuSign Inc (DOCU) is a software - application company listed on US.
Exelixis Inc (EXEL) is a biotechnology company listed on US.
Latest reported DOCU revenue for 2026-07-31 was $1.71B. Net income was $155.9M. DOCU currently screens at market cap $15.74B and trailing P/E 14.8.
Latest reported EXEL revenue for 2026-07-03 was $1.24B. Net income was $422.5M. EXEL currently screens at market cap $12.69B and trailing P/E 16.7.
DOCU currently screens at market cap $15.74B and trailing P/E 14.8. EXEL currently screens at market cap $12.69B and trailing P/E 16.7.
Not investment advice. Open the DOCU and EXEL stock pages for the full models.
Not investment advice.